The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(4-nitrophenyl)-2-(p-tolyl)thiazole-4-carboxamide ID: ALA5265816
Max Phase: Preclinical
Molecular Formula: C17H13N3O3S
Molecular Weight: 339.38
Associated Items:
Names and Identifiers Canonical SMILES: Cc1ccc(-c2nc(C(=O)Nc3ccc([N+](=O)[O-])cc3)cs2)cc1
Standard InChI: InChI=1S/C17H13N3O3S/c1-11-2-4-12(5-3-11)17-19-15(10-24-17)16(21)18-13-6-8-14(9-7-13)20(22)23/h2-10H,1H3,(H,18,21)
Standard InChI Key: FFDADJDKWZQMEG-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
-2.3860 1.8671 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3860 1.0421 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.6726 0.6357 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9655 1.0458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9655 1.8675 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.6744 2.2777 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2539 0.6350 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.4576 1.0458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1692 0.6350 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8808 1.0458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4969 0.4769 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
2.1676 -0.2545 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3470 -0.1625 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5785 -0.9660 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1658 -1.6807 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5806 -2.3880 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3982 -2.3880 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8092 -1.6761 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4002 -0.9660 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8090 -3.0996 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4576 1.8675 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.0976 2.2780 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.8092 1.8671 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.0976 3.0996 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 6 1 0
6 1 2 0
4 7 1 0
7 8 1 0
8 9 1 0
10 9 2 0
10 11 1 0
11 12 1 0
13 12 2 0
9 13 1 0
14 12 1 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 14 2 0
17 20 1 0
8 21 2 0
22 1 1 0
22 23 2 0
22 24 1 0
M CHG 2 22 1 24 -1
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 339.38Molecular Weight (Monoisotopic): 339.0678AlogP: 4.28#Rotatable Bonds: 4Polar Surface Area: 85.13Molecular Species: NEUTRALHBA: 5HBD: 1#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.18CX Basic pKa: ┄CX LogP: 4.59CX LogD: 4.59Aromatic Rings: 3Heavy Atoms: 24QED Weighted: 0.57Np Likeness Score: -2.16
References 1. Sharma PC, Bansal KK, Sharma A, Sharma D, Deep A.. (2020) Thiazole-containing compounds as therapeutic targets for cancer therapy., 188 [PMID:31926469 ] [10.1016/j.ejmech.2019.112016 ]